Viz.ai vs Aidoc

A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.

Viz.ai 50+ FDA-cleared algorithms flag strokes within minutes of a CT scan Visit Aidoc Always-on clinical AI that triages CT findings — ICH, PE, spinal fract... Visit
RECATOOLS Score 8.2 / 10 8.2 / 10
Capability 9.2 9.2
Value for money 7 6.5
Ease of use 7.5 7.5
ASEAN readiness 3.5 5.5
API quality 7 7
Pricing Enterprise Enterprise
Free tier No free tier; hospital pilots available on request No free tier; demo available on request
Paid from Enterprise contracts (estimated six-figure annual fees per health system; volume-based) Custom enterprise pricing; contact sales for per-site or per-volume quotes
Has API
Open source
Free to use
Users Nearly 2,000 U.S. hospitals; 60,000+ providers; 230M+ lives covered nearly 2,000 hospitals worldwide; 150+ US health systems; 60M+ cases/year
Founded 2016 2016
Maker Dr. Chris Mansi (CEO, neurosurgeon) and Dr. David Golan (CTO, machine learning researcher) Aidoc Medical Ltd.
Verdict

Viz.ai has the deployment record to back its claims: nearly 2,000 US hospitals, 50+ FDA-cleared algorithms, and outcomes data — a 44% cut in interfacility stroke transfer times, ~90% clinician click-through on alerts — t...

Aidoc leads the FDA-cleared radiology AI market by clearance count and clinical breadth. Its CARE foundation model — the first cleared for 14 simultaneous abdominal CT indications — is a real step beyond single-condition...

Full review → Full review →
← Back to AI Directory

Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.